|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 39/38 | (2006.01) |
| (11) | Number of the document | 1478394 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03716244.3 |
| Date of filing the European patent application | 2003-02-27 | |
| (97) | Date of publication of the European application | 2004-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2008-07-30 |
| (46) | Date of publication of the claims translation | 2008-11-25 |
| (86) | Number | PCT/US2003/006222 |
| Date | 2003-02-27 |
| (87) | Number | WO 2003/072060 |
| Date | 2003-09-04 |
| (30) | Number | Date | Country code |
| 360257 P | 2002-02-27 | US |
| (72) |
GOMBOTZ, Wayne, R., US
REMMELE, Richard, L., Jr., US
|
| (73) |
Immunex Corporation,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabilizuota TNFR-Fc kompozicija, apimanti argininą |
| Stabilized TNFR-Fc composition comprising arginine |
| Payment date | Validity (years) | Amount | |
| 2022-02-08 | 347.00 EUR |